Summary: Non-small-cell lung cancer remains a deadly form of human cancer even in the era of immunotherapy with existing immunotherapy strategies currently only benefiting a minority of patients. Therefore. the derivation of treatment options. which might extend the promise of immunotherapy to more patients. https://learningstoreextension.shop/product-category/collections/